We know for a fact that some hedge funds have hire
Post# of 72440
That's why the shorts were so frantic to try to find the trial location of Brilacidin-UP, and now of Kevetrin.
And we also know, as Popperian pointed out, that sometimes these scum try to interfere with the trials. PRAN's novel and very promising Alzheimer's drug "failed" because the drug's effect was about the same as placebo. The only thing was -- the placebo group's result was far, far higher than past studies would have indicated was possible. So, many of us think that someone messed with the data to make the drug appear not to work, when in fact it did.
There have been other similar stories. And I still wonder about the "non-compliance" at the one CTIX clinical trial site, which got very different results from all the other sites because of "investigator non-compliance." Kinda makes you understand "why the secrecy," doesn't it?